Deutsche Bank upgraded Sanofi (SNY) to Hold from Sell with a price target of EUR 100, up from EUR 85, following the company’s “solid” Q4 report. With a “reasonable” buyback clarified, competitor risks diminished and a business “in reasonable shape with solid growth near-term,” the firm sees “a diminishing number of reasons to remain outright cautious,” the analyst tells investors.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.